UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 2, 1999
Commission file number 33-33042-NY
CORONADO INDUSTRIES, INC.
----------------------------------------------
(Name of small business issuer in its charter)
Nevada 22-3161629
- ------------------------------- ------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
16929 E. Enterprise Drive, Suite 202, Fountain Hills, AZ 85268
- --------------------------------------------------------------- ---------
(Address of Principal executive offices) (as of date of filing) (Zip Code)
Issuer's telephone number (602) 837-6810
---------------
<PAGE>
ITEM 5. OTHER EVENTS.
On March 2, 1999 Arizona Glaucoma Institute, Inc. ("AGI"), a
wholly-owned subsidiary of Coronado Industries, Inc. (the "Registrant"), closed
its glaucoma treatment center in Scottsdale, Arizona in order to move Dr. Leo
Bores, the Medical Director of AGI to Registrant's headquarters.
Dr. Bores' functions at the Registrant's headquarters will be to take
the Registrant's patented PNT product and process through the final stages of
FDA approval and to be the Registrant's spokesman to ophthalmologists on a
world-wide basis, including the "Innovators" meeting at the American Society of
Cataract and Refractive Surgeons convention in April 1999.
Through its operations at AGI the Registrant was able to establish the
safety and efficacy of its PNT treatment on over 150 glaucoma patients and also
established Medicare payment for its PNT treatment in the Western Region of
Medicare.
The Registrant intends to use the equipment and furniture from the
Scottsdale treatment center at its Clearwater, Florida treatment center, subject
to obtaining sufficient financing to open the Clearwater facility.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial statements of businesses acquired.
Not Applicable.
(b) Pro forma financial information.
Pro forma financial information concerning the impact of the closure of
the Registrant's Scottsdale treatment center will be provided in the
Registrant's Form 10-KSB for the year ended December 31, 1998 which will be
filed with the Commission on or before March 31, 1999.
(c) Exhibits. Not Applicable.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto authorized.
CORONADO INDUSTRIES, INC.
Date: March 16, 1999 By: /s/ Gary R. Smith
--------------- ---------------------------------------
Gary R. Smith, President (Chief
Executive Officer) and Treasurer
(Chief Financial and Accounting Officer)
3
